Case Reports
doi: 10.1001/archsurg.1978.01370130073012.
Portacaval shunt and hyperlipidemia
- PMID: 202223
- PMCID: PMC3221468
- DOI: 10.1001/archsurg.1978.01370130073012
Item in Clipboard
Case Reports
Portacaval shunt and hyperlipidemia
Arch Surg.
1978 Jan.
Abstract
The use of a completely diverting portacaval shunt for the purpose of lowering the serum concentration of cholesterol and low-density lipoproteins is reviewed and a recommendation provided that such a shunt for hyperlipidemia should be considered for type II individuals.
Figures
Serum cholesterol concentrations after portacaval shunt in patient 1.
Hands of patient 1 two weeks before (left) and 16 months after (right) portacaval shunt.
Systemic venous plasma glucose, insulin, and glucagon concentrations in patient 2 with hyperlipidemia, before and after portacaval shunt.
Similar articles
-
Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia.S Afr Med J. 1976 Feb 21;50(8):239-43. S Afr Med J. 1976. PMID: 176738
-
Letter: Portacaval shunt in hyperlipidaemia.Lancet. 1974 Nov 23;2(7891):1263. doi: 10.1016/s0140-6736(74)90774-0. Lancet. 1974. PMID: 4139494 No abstract available.
-
Homozygous hypercholesteraemia and the portacaval shunt. The need for a concerted attack by surgeons and clinical researchers.Lancet. 1974 Aug 24;2(7878):449-51. doi: 10.1016/s0140-6736(74)91828-5. Lancet. 1974. PMID: 4136785 No abstract available.
-
[Surgical methods of correcting hyperlipidemia].Vestn Khir Im I I Grek. 1993 Mar-Apr;150(3-4):143-6. Vestn Khir Im I I Grek. 1993. PMID: 8379062 Review. Russian. No abstract available.
-
[Hyperlipoproteinemias and their skin manifestations].Padiatr Grenzgeb. 1974;13(2-3):99-107. Padiatr Grenzgeb. 1974. PMID: 4369584 Review. German. No abstract available.
Cited by
-
The effect of portacaval shunt upon hepatic cholesterol synthesis and cyclic AMP in dogs and baboons.J Surg Res. 1980 Jan;28(1):1-7. doi: 10.1016/0022-4804(80)90074-8. J Surg Res. 1980. PMID: 6244463 Free PMC article.
-
A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis.Pediatr Nephrol. 2007 Oct;22(10):1803-5. doi: 10.1007/s00467-007-0534-y. Epub 2007 Jul 17. Pediatr Nephrol. 2007. PMID: 17636341
-
Hypercholesterolaemia type II: changes in plasma insulin and glucagon levels after portacaval shunt.J Inherit Metab Dis. 1980;2(3):55-8. doi: 10.1007/BF01801719. J Inherit Metab Dis. 1980. PMID: 6796760
-
Portacaval shunts.World J Surg. 1984 Oct;8(5):688-97. doi: 10.1007/BF01655764. World J Surg. 1984. PMID: 6390989 Review. No abstract available.
-
Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments.Rev Cardiovasc Med. 2023 Nov 9;24(11):311. doi: 10.31083/j.rcm2411311. eCollection 2023 Nov. Rev Cardiovasc Med. 2023. PMID: 39076456 Free PMC article. Review.
References
-
- Starzl TE, Putnam CW, Chase HP, et al. Portacaval shunt in hyperlipoproteinaemia. Lancet. 1973;2:940–944. - PubMed
-
- Krogh L, Wickens JT. Portacaval shunt for hypercholesterolaemia. South Afr Med J. 1974;48:2302. - PubMed
-
- Stein EA, Mieny C, Spitz L, et al. Portacaval shunt in four patients with homozygous hypercholesterolemia. Lancet. 1975;1:832–835. - PubMed
-
- Russell D, Heimann KW, Levin SE, et al. Portacaval shunt for homozygous hypercholesterolemia. Lancet. 1976;2:1205. - PubMed
-
- Cywes S, Davies MRQ, Louw JH, et al. Portacaval shunt in two patients with homozygous type II hyperlipoproteinaemia. South Afr Med J. 1976;50:239–242. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
